Finance

Beta
Lists
MIRM:NASDAQ
Mirum Pharmaceuticals Inc
$123.77
0.00%
(0.00) 1D
Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MIRM...
Mkt. cap
7.55B
Avg. vol.
1.00M
Volume
1.81K
52-wk high
$124.44
52-wk low
$47.89
EPS
-$13.60
Beta
0.50
Shares outstanding
60.98M
No. of employees
418
Mkt. cap
7.55B
Avg. vol.
1.00M
Volume
1.81K
52-wk high
$124.44
52-wk low
$47.89
EPS
-$13.60
Beta
0.50
Shares outstanding
60.98M
No. of employees
418
News stories
From sources across the web
About Mirum Pharmaceuticals Inc
CEO-
Employees418
Founded2018
HeadquartersFoster City, California, United States
SectorBiotechnology
Websitemirumpharma.com
Analyst ratings
Based on 14 analysts giving stock ratings to MIRM in the past 3 months
Strong buy
Buy
14
Hold
0
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for MIRM in the last 3 months.
Highest
Current $123.77
$185.00 (+49.47%)
Average
$145.36 (+17.44%)
Lowest
$115.00 (-7.09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Ulz
Morgan Stanley
Buy
Maintained
$150.00
+21.2%
06/15/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$145.00
+17.2%
06/14/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$185.00
+49.5%
06/15/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$146.00
+18%
06/15/2026
Unknown Analyst
J.P. Morgan
Buy
Initiated
$115.00
-7.1%
05/20/2026
Kalpit Patel
Wolfe Research
Buy
Initiated
$145.00
+17.2%
05/19/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
$154.00
+24.4%
05/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
$165.00
+33.3%
05/07/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
$129.00
+4.2%
05/07/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$138.00
+11.5%
05/07/2026
Lisa Walter
RBC Capital
Buy
Maintained
$142.00
+14.7%
05/07/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
$136.00
+9.9%
05/07/2026
Joseph Thome
TD Cowen
Buy
Reiterated
$145.00
+17.2%
05/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$140.00
+13.1%
04/09/2026
Joe Johoon Kim
RBC Capital
Buy
Maintained
$128.00
+3.4%
04/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
127.78M
133.01M
148.93M
159.88M
Cost of goods sold
23.42M
25.54M
28.26M
28.80M
Cost of revenue
23.42M
25.54M
28.26M
28.80M
Research and development expenses
46.07M
42.96M
51.11M
97.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.29M
61.91M
74.13M
96.33M
Operating expense
109.35M
104.87M
125.24M
194.24M
Total operating expenses
132.77M
130.41M
153.50M
223.04M
Operating income
-4.99M
2.60M
-4.57M
-63.16M
Other non operating income
-214.00K
-5.00K
-18.00K
102.00K
EBT including unusual items
-5.46M
2.64M
-4.96M
-789.68M
EBT excluding unusual items
-5.46M
2.64M
-4.96M
-64.38M
Income tax expense
402.00K
-262.00K
767.00K
475.00K
Effective tax rate
-7.36%
-9.91%
-15.45%
-0.06%
Other operating expenses
-
-
-
-
Net income
-5.86M
2.90M
-5.73M
-790.16M
Net profit margin
-4.59%
2.18%
-3.85%
-494.21%
Earnings per share
-0.12
0.05
-0.12
-1.08
Interest and investment income
3.03M
3.25M
3.42M
3.40M
Interest expense
-3.59M
-3.61M
-3.60M
-3.62M
Net interest expenses
-556.00K
-355.00K
-178.00K
-215.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.07M
8.66M
1.51M
-56.29M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of MIRM
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer